• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前超声绘图与放射性核素导向隐匿性病灶定位在局部复发性/持续性甲状腺乳头状癌患者中的联合应用:一种中央区再次手术的实用方法。

Combination of preoperative ultrasonographic mapping and radioguided occult lesion localization in patients with locally recurrent/persistent papillary thyroid carcinoma: a practical method for central compartment reoperations.

机构信息

Department of Nuclear Medicine, Gülhane Military Medical Academy, Ankara, Turkey.

出版信息

Clin Nucl Med. 2010 Nov;35(11):847-52. doi: 10.1097/RLU.0b013e3181f48403.

DOI:10.1097/RLU.0b013e3181f48403
PMID:20940540
Abstract

PURPOSE

To improve the surgical success and reduce the complication rates, we combine our routine preoperative ultrasound (US) mapping technique with radioguided occult lesion localization (ROLL) in patients with papillary thyroid cancer recurrences in central compartment.

MATERIALS AND METHODS

In the morning of surgery, biopsy proven recurrent/persistent tumoral lesions were plotted on a sketch and injected with Tc-99m labeled macroaggregated albumin under US guidance. Thyroid bed exploration was carried out based on the location of biopsy proven lesion with the guidance of intraoperative gamma probe and neck map. The lymphoadipose tissues showing high count rates were resected and labeled separately for histopathologic study.

RESULTS

Despite extensive scarring in some patients probe safely guided to lesions. Noninjected tumor foci were searched and successfully resected in the light of neck map that showing topographic relation of injected and noninjected lesions. Among total of 41 excised lesions, 28 metastatic foci ranging from 3 to 38 mm in largest diameter were recognized at final histologic examination. Combination of preoperative mapping with ROLL was found helpful by the operating surgeons in all patients, respectively. Except 2 patients with known distant metastases, undetectable thyroglobulin levels were reached 6 weeks after surgery.

CONCLUSIONS

The use of preoperative US-mapping with ROLL in patients with nonpalpable recurrent/persistent papillary thyroid cancer in central compartment is technically safe and effective method. Combination of techniques provides better information about topographical relations of recurrent/persistent lesions during surgery.

摘要

目的

为了提高手术成功率并降低并发症发生率,我们将常规术前超声(US)定位技术与放射性隐匿性病变定位(ROLL)相结合,应用于中央区复发性甲状腺乳头状癌患者。

材料和方法

手术当天早晨,对经活检证实的复发性/持续性肿瘤病变进行绘图,并在超声引导下注射 Tc-99m 标记的巨聚合白蛋白。根据活检证实的病变位置,在术中伽马探针和颈部图的引导下进行甲状腺床探查。切除显示高计数率的淋巴脂肪组织,并分别标记进行组织病理学研究。

结果

尽管部分患者存在广泛的疤痕,但探针仍能安全地引导至病变部位。根据颈部图寻找未注射的肿瘤病灶,并成功切除,颈部图显示了注射和未注射病变的解剖关系。在总共切除的 41 个病变中,最终组织学检查发现 28 个转移灶,最大直径为 3 至 38 毫米。所有患者的手术医生均认为术前定位与 ROLL 相结合具有帮助。除 2 例已知远处转移的患者外,所有患者术后 6 周均达到无法检测到甲状腺球蛋白的水平。

结论

在中央区触诊不到的复发性/持续性甲状腺乳头状癌患者中,使用术前 US 定位联合 ROLL 是一种安全有效的方法。两种技术的结合可以在手术中提供关于复发性/持续性病变的更好的解剖关系信息。

相似文献

1
Combination of preoperative ultrasonographic mapping and radioguided occult lesion localization in patients with locally recurrent/persistent papillary thyroid carcinoma: a practical method for central compartment reoperations.术前超声绘图与放射性核素导向隐匿性病灶定位在局部复发性/持续性甲状腺乳头状癌患者中的联合应用:一种中央区再次手术的实用方法。
Clin Nucl Med. 2010 Nov;35(11):847-52. doi: 10.1097/RLU.0b013e3181f48403.
2
Radioguided occult lesion localization for locally recurrent thyroid carcinoma.
Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2915-2919. doi: 10.1007/s00405-017-4563-2. Epub 2017 Apr 13.
3
The rate of operative success achieved with radioguided occult lesion localization and intraoperative ultrasonography in patients with recurrent papillary thyroid cancer.放射性引导隐匿性病变定位和术中超声检查在复发性甲状腺乳头状癌患者中实现的手术成功率。
Surgery. 2014 Nov;156(5):1116-26. doi: 10.1016/j.surg.2014.04.012. Epub 2014 Jun 19.
4
Radioguided occult lesion localization in patients with recurrent thyroid cancer.放射性引导下复发性甲状腺癌患者隐匿性病变的定位
Eur Arch Otorhinolaryngol. 2019 Jun;276(6):1757-1766. doi: 10.1007/s00405-019-05377-w. Epub 2019 Mar 18.
5
Radioguided surgery with combined use of gamma probe and hand-held gamma camera for treatment of papillary thyroid cancer locoregional recurrences: a preliminary study.放射性核素导向手术联合应用γ探测仪和手持式γ相机治疗甲状腺乳头状癌局部区域复发:初步研究。
Eur Rev Med Pharmacol Sci. 2013 Dec;17(24):3362-6.
6
Excision efficiency of radioguided occult lesion localization in reoperative thyroid and parathyroid surgery.放射性核素导向隐匿性病灶定位在甲状腺和甲状旁腺再次手术中的切除效率。
Thyroid. 2010 Nov;20(11):1271-8. doi: 10.1089/thy.2009.0441. Epub 2010 Oct 18.
7
Hook needle-guided excision of recurrent differentiated thyroid cancer in previously operated neck compartments: a safe technique for small, nonpalpable recurrent disease.钩针引导下切除先前手术颈部区域的复发性分化型甲状腺癌:一种针对微小、不可触及复发病灶的安全技术。
J Clin Endocrinol Metab. 2006 Dec;91(12):4943-7. doi: 10.1210/jc.2006-0386. Epub 2006 Sep 12.
8
Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma.复发性/持续性甲状腺乳头状癌安全有效的甲状腺床再次手术算法
Head Neck. 2007 Dec;29(12):1069-74. doi: 10.1002/hed.20634.
9
Radioguided surgery of thyroid carcinoma recurrences: the role of preoperative (99m)Tc-labeled human serum albumin macroaggregates-SPECT/CT mapping.放射性核素导向手术治疗甲状腺癌复发:术前(99m)Tc 标记人血清白蛋白聚合体 SPECT/CT 显像的作用。
Clin Nucl Med. 2013 Apr;38(4):e207-9. doi: 10.1097/RLU.0b013e3182641d01.
10
Radioguided occult lesion localization of cervical recurrences from differentiated thyroid cancer: technical feasibility and clinical results.放射性引导下分化型甲状腺癌颈部复发隐匿性病变的定位:技术可行性及临床结果
Q J Nucl Med Mol Imaging. 2013 Dec;57(4):401-11.

引用本文的文献

1
Radioguided Surgery of Non-palpable Neck Lymph Node in Lymphoma Patients.淋巴瘤患者不可触及颈部淋巴结的放射性引导手术
Indian J Otolaryngol Head Neck Surg. 2019 Dec;71(4):430-434. doi: 10.1007/s12070-019-01591-4. Epub 2019 Jan 19.
2
MINIMALLY INVASIVE PARATHYROIDECTOMY FOR PRIMARY HYPERPARATHYROIDISM.原发性甲状旁腺功能亢进症的微创甲状旁腺切除术
Acta Endocrinol (Buchar). 2019 Apr-Jun;15(2):182-186. doi: 10.4183/aeb.2019.182.
3
Radioguided occult lesion localization in patients with recurrent thyroid cancer.放射性引导下复发性甲状腺癌患者隐匿性病变的定位
Eur Arch Otorhinolaryngol. 2019 Jun;276(6):1757-1766. doi: 10.1007/s00405-019-05377-w. Epub 2019 Mar 18.
4
Guided intraoperative scintigraphic tumor targeting of metastatic cervical lymph nodes in patients with differentiated thyroid cancer: a single-center report.分化型甲状腺癌患者术中放射性核素显像引导下转移性颈部淋巴结的肿瘤靶向定位:单中心报告
Arch Endocrinol Metab. 2018 Oct;62(5):495-500. doi: 10.20945/2359-3997000000068.
5
Radioguided occult lesion localization for locally recurrent thyroid carcinoma.
Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2915-2919. doi: 10.1007/s00405-017-4563-2. Epub 2017 Apr 13.
6
The contributions of gamma probe to lesion detectability and surgical safety in recurrent thyroid cancer at risk.γ探测器对复发性高危甲状腺癌中病变可探测性及手术安全性的贡献。
Mol Imaging Radionucl Ther. 2013 Aug;22(2):56-9. doi: 10.4274/Mirt.148. Epub 2013 Aug 1.
7
Highlights of the EANM Congress Barcelona 2009: increasing our impact in diagnostic imaging.2009 年 EANM 巴塞罗那大会亮点:提高我们在诊断成像中的影响力。
Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):799-820. doi: 10.1007/s00259-009-1374-8. Epub 2010 Mar 3.